tirzepatide y nad for diabetes: on track to SURPASS current therapy Next Health Fredericksburg - Regenerative

In 2022, 2.5 billion adults around the world were overweight, and nearly 900 million were living with obesity

These provide sustained energy and help prevent fatigue that can accompany reduced intake

People who have been on their medication for 4 or more weeks and have stable gastrointestinal function

Across all eight markets, obesity prevalence is expected to rise through to 2050, particularly in Mexico (+18%), Brazil (+17%) and Saudi Arabia (+16%) demonstrating the increasing unmet need to tackle population weight

The peptide market is broad, and not every product is aligned with professional research standards